Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Bionano Genomics Inc (BNGO)

NASDAQ
Currency in USD
Disclaimer
0.8158
-0.0397(-4.64%)
Closed
After Hours
0.8100-0.0058(-0.711%)

BNGO Price Commentary

MORE THAN 15 MILLION SHARES TRADED IN 15 MINUTES.This technology cant beheld down and therefore the shorts will lose.
Higher volumes, is something big going to happen?
doesnt matter.
No institutional investors are selling. VANGUARD are literally holding over 7 million shares. This dip is a major invitation for more institutions to get behind us. Just make sure that what you have invested is not essential to you for the rest of the year and you’ll return to major gains if patience is your virtue.
Vanguard bought at $2. You also dont know if they’re selling. I get your good intentions, but you come across as pretty condescending.
Jesus Christ, where is the floor. Please don’t say $2
I would say $3 dollars is where i buy more
it's hurt seeing this .....ill average at 3
Sounds like a Thai Stir Fry meal
This SP, isn’t going anywhere in the short term. Id be suprised if it got above $9 prior to the Q1 results.
Do some DD. Huge global potential
What a Rip off !!!!
What a scam of a company
Whats up grrroup
179083 gggggg mmaaaailll.
https://www.sec.gov/Archives/edgar/data/1411690/000114036121009770/nt10022040x1_424b5.htm
stops triggered! got crushed
Better than expected results is not helping at all
I agree senior Potts!
Happy with the the Q4 earnings abd guidance, Saphyr 2.0 coming Q4, with a throughput of 70,000 genomes a year (currently 5,000). At $500 per genome and getting insurance to pay, thats alot over 150 systems in play.Just the start of an exciting journey. Buying more at month end 💷💵
BNGO, AND BNGO WAS ITS NAME HO!
The way i see it, forget about your investment. It is a long term play. Check again in 2025.
Lets hope it can end $9+. In 4 days, more important than the revenue results, will be the guidance - This could be the catalyst for; more institutional investment & a sharp rise. Fingers crossed 🤞🏼 BNGO lovers!
https://bionanogenomics.com/videos/bionano-optical-genome-mapping-and-southern-blot-analysis-for-fshd-detection/
A nice finish of $10+ on Friday would be some turnaround. Well played to all the holders!
Drinks on you, Pepe, when it hits $50
absolutely!!
I am holding it since 0.77$ and will hold it for a long time. I believe that this company have future. Nano dimentions and Invitae too.
SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 23 rd , 2021 at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2020 and to highlight recent corporate progress.
Drs. Beggs and Brownstein are enrolling 50 patients each with MIS-C, severe COVID-19, and asymptomatic or mildly affected patients and will compare their genomes using OGM with Saphyr and with NGS.
full: 🔥🔥🔥Dr. Alan Beggs and Dr. Catherine Brownstein, Boston Children’s Hospital (BCH) discuss their previously announced study on the genomes of patients with Multisystem Inflammatory Syndrome in Children (MIS-C), a severe inflammatory attack of multiple organs weeks after COVID-19 infection in children with an average age of 8 years old. BCH has reported 67 cases of hospitalized MIS-C, and the Children’s Rare Disease Cohort Initiative has banked their specimens. Drs. Beggs and Brownstein are enrolling 50 patients each with MIS-C, severe COVID-19, and asymptomatic or mildly affected patients and will compare their genomes using OGM with Saphyr and with NGS.
bionanogenomics.com/videos/why-do-some-children-exposed-to-the-coronavirus-go-on-to-develop-mis-c/
https://bionanogenomics.com/videos/why-do-some-children-exposed-to-the-coronavirus-go-on-to-develop-mis-c/
Buy buy buy. More to come
BNGO did well today. More to come, not worried
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.